Triple Moving Average Crossover
|Bid||140.10 x 1300|
|Ask||141.86 x 1000|
|Day's Range||140.30 - 143.50|
|52 Week Range||101.36 - 147.87|
|Beta (5Y Monthly)||0.17|
|PE Ratio (TTM)||15.92|
|Earnings Date||Apr 22, 2020|
|Forward Dividend & Yield||2.96 (2.12%)|
|Ex-Dividend Date||Feb 12, 2020|
|1y Target Est||146.21|
Lilly (LLY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here’s what you need to know about the coronavirus outbreak to navigate the markets today. • U.K. Prime Minister Boris Johnson has been admitted to the hospital after experiencing what a spokesperson called “persistent symptoms” of Covid-19. • The American economy won’t begin to recover until there’s a “highly effective drug in the hands of doctors that can mitigate the risk,” of coronavirus infection, former head of the Food and Drug Administration, Dr. Scott Gottlieb, said on CBS’ Face the Nation Sunday.
With the coronavirus crisis gripping the economy, medical stocks such as Eli Lilly, Dexcom, Vertex Pharmaceuticals, Masimo and Veeva Systems look healthy.
Eli Lilly is the IBD Stock Of The Day after the pharma giant reaffirmed 2020 targets for solid earnings growth. Now, LLY stock is eyeing a breakout.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.
J&J (JNJ) to begin human clinical studies on coronavirus vaccine candidate in September. Sanofi (SNY) begins outside U.S. study on Kevzara for severe COVID-19 infection.
Healthcare has held up better than most S&P 500 sectors. Since the S&P 500 hit an all-time high on Feb. 19, healthcare is down about 18% as of Wednesday, while the benchmark index has tumbled 27%. The sector is typically considered a defensive area of the market because some investors believe consumers will continue buying healthcare products even during uncertain times.
Eli Lilly (LLY) stock closed the first quarter above where it started, which was no easy task. So let's dive into why investors might want to buy LLY stock right now...
Major drugmakers Merck & Co. Inc.,, Pfizer Inc. and Eli Lilly and Co. are joining together to establish volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.
Medical Professionals Across Merck, Pfizer and Eli Lilly Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.
How far off is Eli Lilly and Company (NYSE:LLY) from its intrinsic value? Using the most recent financial data, we'll...
Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that could help it fend off competition from Eli Lilly and Co in the market for migraine drugs. The Patent Trial and Appeal Board (PTAB) upheld the validity of three Teva patents on its migraine treatment Ajovy, rejecting arguments by Eli Lilly that they were invalid. In a separate legal action filed in 2018, Teva accused Eli Lilly's competing drug Emgality of infringing the same patents.